PF-06409577 Activates AMPK Signaling and Inhibits Osteosarcoma Cell Growth

Osteosarcoma (OS) is a common primary bone malignancy. We here investigated the potential activity of PF-06409577, a novel, potent, and direct activator of AMP-activated protein kinase (AMPK), against human OS cells. In established (U2OS, MG-63, and SaOs-2 lines) and primary human OS cells, PF-06409...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yun-Rong, Zhang, Xiang-Yang, Wu, Qiu-Ping, Yu, Cheng-Jian, Liu, Yuan-Yuan, Zhang, Yun-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316637/
https://www.ncbi.nlm.nih.gov/pubmed/34336655
http://dx.doi.org/10.3389/fonc.2021.659181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316637/
https://www.ncbi.nlm.nih.gov/pubmed/34336655
http://dx.doi.org/10.3389/fonc.2021.659181

Ejemplares similares